Coronavirus Update: After FabiFlu, Now Potential COVID-19 Drug Covifor and Cipremi To Hit The Market
While Glenmark Pharmaceuticals has launched favipiravir under the brand name FabiFlu for treatment of mild to moderate cases of Covid-19, Cipla and Hetero Labs have...